October 1, 2019 (MLN): The Board of Directors of Ismail Industries Limited has decided to further increase the long-term equity investment in its subsidiary company, Hudson Pharma (Pvt.) Limited.
The decision was taken during the 30th Annual General Meeting of the company, wherein the Shareholders granted their approval to increase the investment from Rs. 500 million to Rs. 1 billion, in order to meet the operational expenses and working capital requirements of the subsidiary company.
Copyright Mettis Link News